Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • About
    • Our Story
    • CIFAR 40
    • Awards
    • Partnerships
    • President’s Message
    • Publications & Reports
    • Careers
    • Equity, Diversity & Inclusion
  • News
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Solution Network Members
    • Staff Directory
    • Leadership
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
    • Global Call for Ideas
    • Action on Covid-19
  • Events
    • Public Events
    • Invitation-only Meetings
  • Support Us
  • fr
  • Home
  • Bio

Follow Us

post_content

Alexander Kwarteng

Appointment

  • CIFAR Azrieli Global Scholar 2017-2019
  • Humans & the Microbiome

Connect

ResearchGate

About

Alexander Kwarteng’s research seeks to elucidate the immunology and molecular mechanisms underlying diseases of poverty.

He is particularly interested in neglected tropical diseases such as human filarial infection. By extension, his team focuses on understanding the complex host-microbiome interactions and molecular underpinning behind the array of pathologies that people with filarial infections present with. Kwarteng has been actively involved in several clinical trials targeted at eliminating filariasis in affected communities in Ghana. His team develops and promotes the use of innovative strategies to alleviate the pain and burden of people suffering from lymphedema (elephantiasis) and hydrocele. To do this, they take an interdisciplinary approach, with a cultural perspective, to fight social stigmatization and depressive mental illness in lymphatic filariasi–endemic communities in Ghana. In recent years Kwarteng’s research interests have expanded to include cancer genomics, computational immunology and emerging infectious diseases.

Awards

  • Deutscher Akademischer Austauschdienst (DAAD) Scholar

Relevant Publications

  • Kwarteng, A., and S.T. Ahuno. “Immunity in filarial infections: lessons from animal models and human studies.” Scand J Immunol (2017).

  • Kwarteng, A., S.T. Ahuno, and F.O. Akoto. “Killing filarial nematode parasites: role of treatment options and host immune response.” Infect Dis Poverty 5, no. 1 (2016): 86.

  • Debrah, A.Y. et al. “Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial.” Clin Infect Dis. 61, no. 4 (2015): 517–26.

  • Arndts, K. et al. “Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti.” PLoS Negl Trop Dis. 6, no. 4 (2012).

  • Mand, S. et al. “Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial.” Clin Infect Dis. 55, no. 5 (2012): 621–30.

Institution

  • Kwame Nkrumah University of Science and Technology

Department

Department of Biochemistry and Biotechnology

Education

  • PhD (Molecular Biomedicine), University of Bonn
  • MPhil (Clinical Microbiology), Kwame Nkrumah University of Science and Technology
  • BSc (Biological Science), Kwame Nkrumah University of Science and Technology

Country

  • Ghana

Support Us

CIFAR is a registered charitable organization supported by the governments of Canada, Alberta and Quebec, as well as foundations, individuals, corporations and Canadian and international partner organizations.

Donate Now
CIFAR header logo

Subscribe

Stay up to date on news & ideas from CIFAR.

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2022 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more